SCHEMBL5219617

SCHEMBL5219617

COC(=O)c1cc(N)c(C)c(N2CCCC2=O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.50
NPC1 O15118 3/20 0.48
KDM4E B2RXH2 3/20 0.48
RAB9A P51151 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
CYP2C9 P11712 3/20 0.46
CYP3A4 P08684 1/20 0.46
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
HPGD P15428 4/20 0.42
ALDH1A1 P00352 4/20 0.42
MAPT P10636 2/20 0.42
CASP6 P55212 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5219875 0.85 NPC1 (0.47) HSD17B10NPC1KDM4ERAB9ASMN1; SMN2
SCHEMBL7240806 0.84 KDM4E (0.65) HSD17B10NPC1KDM4ERAB9ASMN1; SMN2
SCHEMBL5219674 0.82 CYP2C9 (0.45) HSD17B10NPC1KDM4ERAB9ASMN1; SMN2
SCHEMBL5223591 0.82 CYP2C9 (0.45) HSD17B10NPC1KDM4ERAB9ASMN1; SMN2
SCHEMBL5226061 0.81 MEN1 (0.48) NPC1KDM4ESMN1; SMN2CYP2C9CYP3A4
SCHEMBL5223383 0.81 CTSD (0.47) HSD17B10CYP2C9CYP3A4MEN1KMT2A
SCHEMBL475775 0.77 MEN1 (0.56) NPC1RAB9ASMN1; SMN2CYP2C9CYP3A4
SCHEMBL5219444 0.77 MEN1 (0.56) NPC1RAB9ASMN1; SMN2CYP2C9CYP3A4
SCHEMBL5223336 0.76 CYP2C9 (0.44) HSD17B10NPC1KDM4ERAB9ASMN1; SMN2
SCHEMBL9077842 0.75 KDM4E (0.58) HSD17B10NPC1KDM4ERAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed